Compounds > isoalantolactone
Page last updated: 2024-08-25

isoalantolactone and Breast Neoplasms

isoalantolactone has been researched along with Breast Neoplasms in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, L; Feng, L; Jia, X; Liu, D; Song, J; Wang, J; Zhang, Z1
Li, Z; Mao, J; Qi, X; Qin, B; Wu, D1

Other Studies

2 other study(ies) available for isoalantolactone and Breast Neoplasms

ArticleYear
Isoalantolactone inhibits the migration and invasion of human breast cancer MDA-MB-231 cells via suppression of the p38 MAPK/NF-κB signaling pathway.
    Oncology reports, 2016, Volume: 36, Issue:3

    Topics: Antineoplastic Agents; Breast Neoplasms; Cell Adhesion; Cell Line, Tumor; Cell Movement; Down-Regulation; Female; Humans; MAP Kinase Signaling System; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neoplasm Invasiveness; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Sesquiterpenes; Signal Transduction; Transcription Factor RelA

2016
Isoalantolactone induces apoptosis in human breast cancer cells via ROS-mediated mitochondrial pathway and downregulation of SIRT1.
    Archives of pharmacal research, 2016, Volume: 39, Issue:10

    Topics: Apoptosis; Breast Neoplasms; Cell Survival; Dose-Response Relationship, Drug; Down-Regulation; Female; Humans; MCF-7 Cells; Mitochondria; Reactive Oxygen Species; Sesquiterpenes; Signal Transduction; Sirtuin 1

2016